{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T07:30:58.427634+00:00","company":{"ticker":"TCNNF","cik":1754195,"company_name":"Trulieve Cannabis Corp."},"pagination":{"limit":100,"returned":7,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"d7c524092a67745920b8b4243d07aea253e0ee23","cik":1754195,"ticker":"TCNNF","company_name":"Trulieve Cannabis Corp.","filed_at":"2026-05-07T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$2 million","period_text":"first quarter ended March 31, 2026","report_date":"2026-05-07","result_type":"reported_results","revenue_text":"$287 million"},"claim":"Trulieve Cannabis Corp. reported first quarter ended March 31, 2026 results: revenue $287 million, net income $2 million.","evidence_excerpt":"as Exhibit 99.1. \n\n--- EX-99.1 (EX-99.1) ---\n\nTrulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation • First quarter revenue of $287 million, with 59% gross margin • Positive net income of $2 million and Adjusted EBITDA of $100 million* • Rescheduling of medical marijuana to Schedule III enabled applications for DEA","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001754195-26-000030","anchor_url":"https://secwatch.observer/filing/0001754195-26-000030#claim-d7c524092a67745920b8b4243d07aea253e0ee23","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1754195/000175419526000030/0001754195-26-000030-index.htm"},{"fact_type":"debt_financing","fact_key":"a8ef51136d2cdb1e2ab9b4c1a8c1104b24085894","cik":1754195,"ticker":"TCNNF","company_name":"Trulieve Cannabis Corp.","filed_at":"2026-01-29T23:59:59+00:00","payload":{"counterparty":null,"effective_date":"2026-01-29","event":"incurrence","instrument_type":"senior_notes","interest_rate_text":"10.5% per annum","item_codes_triggered":["2.03"],"maturity_text":"December 17, 2030","principal_text":"U.S. $60 million aggregate principal amount"},"claim":"Trulieve Cannabis Corp. incurred senior notes of U.S. $60 million aggregate principal amount at 10.5% per annum maturing December 17, 2030.","evidence_excerpt":"On January 29, 2026, Trulieve Cannabis Corp. (the “Company”) issued an additional U.S. $60 million aggregate principal amount of its 10.5% senior secured notes due December 17, 2030 (the “Additional Notes”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001754195-26-000005","anchor_url":"https://secwatch.observer/filing/0001754195-26-000005#claim-a8ef51136d2cdb1e2ab9b4c1a8c1104b24085894","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1754195/000175419526000005/0001754195-26-000005-index.htm"},{"fact_type":"material_agreement","fact_key":"e85d99ec046fb770d5c8b23dc8b0c9669839d4d3","cik":1754195,"ticker":"TCNNF","company_name":"Trulieve Cannabis Corp.","filed_at":"2026-01-29T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Indenture","agreement_type":"notes_offering","counterparty":"Odyssey Trust Company","effective_date":"2026-01-29","item_codes_triggered":["1.01"],"value_text":"U.S. $60 million aggregate principal amount"},"claim":"Trulieve Cannabis Corp. entered into Indenture with Odyssey Trust Company valued at U.S. $60 million aggregate principal amount (effective 2026-01-29).","evidence_excerpt":"On January 29, 2026, Trulieve Cannabis Corp. (the “Company”) issued an additional U.S. $60 million aggregate principal amount of its 10.5% senior secured notes due December 17, 2030 (the “Additional Notes”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001754195-26-000005","anchor_url":"https://secwatch.observer/filing/0001754195-26-000005#claim-e85d99ec046fb770d5c8b23dc8b0c9669839d4d3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1754195/000175419526000005/0001754195-26-000005-index.htm"},{"fact_type":"debt_financing","fact_key":"8206d45c47ee35527367ce6f892cfcd80798f358","cik":1754195,"ticker":"TCNNF","company_name":"Trulieve Cannabis Corp.","filed_at":"2025-12-17T23:59:59+00:00","payload":{"counterparty":"Odyssey Trust Company","effective_date":"2025-12-17","event":"incurrence","instrument_type":"senior_notes","interest_rate_text":"10.5%","item_codes_triggered":["2.03"],"maturity_text":"December 17, 2030","principal_text":"$140,000,000 aggregate principal amount"},"claim":"Trulieve Cannabis Corp. incurred senior notes of $140,000,000 aggregate principal amount with Odyssey Trust Company at 10.5% maturing December 17, 2030.","evidence_excerpt":"On December 17, 2025, Trulieve Cannabis Corp. (the “Company”) issued $140,000,000 aggregate principal amount of its 10.5% senior secured notes due December 17, 2030 (the “Notes”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001754195-25-000074","anchor_url":"https://secwatch.observer/filing/0001754195-25-000074#claim-8206d45c47ee35527367ce6f892cfcd80798f358","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1754195/000175419525000074/0001754195-25-000074-index.htm"},{"fact_type":"executive_change","fact_key":"ea37c620c6","cik":1754195,"ticker":"TCNNF","company_name":"Trulieve Cannabis Corp.","filed_at":"2025-03-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-03-06","interim":true,"role":"Interim Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Ryan Blust was appointed as Interim Chief Financial Officer at Trulieve Cannabis Corp..","evidence_excerpt":"The Company has appointed Ryan Blust, the Company’s Vice President, Finance, as its interim Chief Financial Officer, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001754195-25-000003","anchor_url":"https://secwatch.observer/filing/0001754195-25-000003#claim-ea37c620c6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1754195/000175419525000003/0001754195-25-000003-index.htm"},{"fact_type":"executive_change","fact_key":"fd5c77436e","cik":1754195,"ticker":"TCNNF","company_name":"Trulieve Cannabis Corp.","filed_at":"2025-03-07T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-03-06","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Ryan Blust","successor_named":true},"claim":"Wes Getman resigned as Chief Financial Officer at Trulieve Cannabis Corp..","evidence_excerpt":"On March 6, 2025, Wes Getman resigned from his position as Chief Financial Officer of Trulieve Cannabis Corp. (the “Company”) to pursue other opportunities.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001754195-25-000003","anchor_url":"https://secwatch.observer/filing/0001754195-25-000003#claim-fd5c77436e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1754195/000175419525000003/0001754195-25-000003-index.htm"},{"fact_type":"earnings_release","fact_key":"b88d96ae3926e6223d93e49331a0afe95f944d50","cik":1754195,"ticker":"TCNNF","company_name":"Trulieve Cannabis Corp.","filed_at":"2024-05-09T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"net loss of $23 million","period_text":"the quarter ended March 31, 2024","report_date":"2024-05-09","result_type":"reported_results","revenue_text":"$298 million"},"claim":"Trulieve Cannabis Corp. reported the quarter ended March 31, 2024 results: revenue $298 million, net income net loss of $23 million.","evidence_excerpt":"---\n\ntcnnf-2024xq1xexx991 Exhibit 99.1 Trulieve Reports First Quarter 2024 Results Demonstrating Core Business Strength and Cash Generation • First quarter performance of $298 million in revenue, up 4% sequentially, and 58% gross margin • Strong cash flow from operations of $139 million and free cash flow of $124 million* in Q1 2024 • Definitive progress made","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-021918","anchor_url":"https://secwatch.observer/filing/0001628280-24-021918#claim-b88d96ae3926e6223d93e49331a0afe95f944d50","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1754195/000162828024021918/0001628280-24-021918-index.htm"}]}